Reset filter
Keywords
Parkinsons Disease ×
Mostra di più Keywords
Sommario
  1. 1. Klinische studie
  2. 2. Routinedocumentatie
  3. 3. Register-/kohortstudies
  4. 4. Kwaliteitswaarborging
  5. 5. Datastandaard
  6. 6. Patiëntenvragenlijst
  7. 7. Medisch vakgebied
Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

396 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

visit week 12 physical examination Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 03-11-17 - 1 modulo, 10 itemgroups, 16 elementi, 1 linguaggio
Itemgroups: administrative data, vital signs, 12-lead ECG, central laboratory, clinical global impression questionnaire, unified parkinson's disease rating scale questionnaire, parkinson's disease sleep scale, Beck Depression Inventory, EPWORTH SLEEPINESS SCALE, STABLE UPDRS MOTOR SCORE
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

CRF tracking/review form (TRF) Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 03-11-17 - 1 modulo, 4 itemgroups, 11 elementi, 1 linguaggio
Itemgroups: administrative data, Screening failure, CRF tracking review form, Comments and signature
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Questionnaires Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 02-11-17 - 1 modulo, 2 itemgroups, 6 elementi, 1 linguaggio
Itemgroups: administrative data, Questionnaires
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

study conclusion Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 18-10-17 - 1 modulo, 5 itemgroups, 10 elementi, 1 linguaggio
Itemgroups: administrative data, Study conclusion, Pregnancy information, Overall compliance, Investigator signature
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Serious adverse events Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 18-10-17 - 1 modulo, 14 itemgroups, 56 elementi, 1 linguaggio
Itemgroups: administrative data, Serious adverse event, Serious adverse event, Seriousness, Demography data, Recurrence of SAE, Possible Causes of SAE Other Than Investigational Product, Relevant Medical Conditions, Other relevant risk factors, Relevant concomitant medications, Details of Investigational Product, Details of relevant Assessments, Narrative Remarks, Investigator information
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Non-serious adverse events Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 18-10-17 - 1 modulo, 3 itemgroups, 11 elementi, 1 linguaggio
Itemgroups: administrative data, Non-serious adverse events, Non-serious adverse events
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

concomitant medication Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 18-10-17 - 1 modulo, 3 itemgroups, 11 elementi, 1 linguaggio
Itemgroups: administrative data, concomitant medication, concomitant medication
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Unscheduled visit 6 compliance Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 17-10-17 - 1 modulo, 3 itemgroups, 10 elementi, 1 linguaggio
Itemgroups: administrative data, investigational product, compliance
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Unscheduled visit 5 compliance Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 17-10-17 - 1 modulo, 3 itemgroups, 10 elementi, 1 linguaggio
Itemgroups: administrative data, investigational product, compliance
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Follow-up visit week 38 compliance Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 17-10-17 - 1 modulo, 3 itemgroups, 10 elementi, 1 linguaggio
Itemgroups: administrative data, investigational product, compliance
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Unscheduled visit 3 compliance Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 17-10-17 - 1 modulo, 3 itemgroups, 10 elementi, 1 linguaggio
Itemgroups: administrative data, investigational product, compliance
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Unscheduled visit 2 compliance Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 17-10-17 - 1 modulo, 3 itemgroups, 10 elementi, 1 linguaggio
Itemgroups: administrative data, investigational product, compliance
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial